slf22 sympth1
Name
sttn2
Label
Hmg Coa Reducatace Inhibitors (Statins) (SHHS2)
Description

Participant taking HMG COA REDUCATACE INHIBITORS (STATINS) within two weeks of the SHHS2 visit. All medications were recorded during the interview, and medication information was later categorized by physician review.

Domain
noyes01
  • 0: No
  • 1: Yes
  • 8: Don't know
Type
choices
Tags
dyslipidemia hypercholesterolemia hyperlipidemia STTN2
Hmg Coa Reducatace Inhibitors (Statins) (SHHS2) vs SHHS Visit Number
Visit 1 Interim Follow-up Visit Visit 2 CVD Outcomes
Total - - 4,080 -
No - - 2,617 -
Yes - - 1,003 -
Don't know - - - -
Unknown - - 460 -
Hmg Coa Reducatace Inhibitors (Statins) (SHHS2) vs Age at SHHS1
Visit 2
35-44 years 45-54 years 55-64 years 65-74 years 75-84 years 85 years or older Total
Total 184 707 1,321 1,200 624 44 4,080
No 159 533 817 684 395 29 2,617
Yes 17 114 331 372 158 11 1,003
Don't know - - - - - - -
Unknown 8 60 173 144 71 4 460
Hmg Coa Reducatace Inhibitors (Statins) (SHHS2) vs Gender
Visit 2
Male Female Total
Total 1,861 2,219 4,080
No 1,131 1,486 2,617
Yes 530 473 1,003
Don't know - - -
Unknown 200 260 460
Hmg Coa Reducatace Inhibitors (Statins) (SHHS2) vs Race
Visit 2
White Black Other Total
Total 3,587 256 237 4,080
No 2,261 182 174 2,617
Yes 901 60 42 1,003
Don't know - - - -
Unknown 425 14 21 460